Amgen (AMGN) is drawing fresh attention after Phase 3 data for subcutaneous TEPEZZA in Thyroid Eye Disease and strong weight ...
Health sector updates include AG1 exploring business sale options, genetic links to effective GLP-1 obesity drugs, Amgen's lung cancer drug approval in China, Kennedy's vaccine advisory panel focusing ...
Shanghai: Amgen's lung cancer drug tarlatamab has won approval from China's National Medical Products Administration, its ...
The trial compares two active regimens of pegloticase plus methotrexate, both aimed at hard-to-treat gout that does not respond to standard drugs. One arm uses 16 mg of pegloticase by IV every four ...
In this article, we will look at the stocks Jim Cramer discussed alongside the tech market divide. The host of CNBC’s Mad ...
The health sector sees significant developments with C4 Therapeutics and Roche forming a billion-dollar cancer drug deal, AG1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results